Endothelial USP2a-METTL16 loop amplifies IL-6 signaling in pulmonary hypertension
作者
Hanqing Zhu
出处
期刊:The European respiratory journal [European Respiratory Society] 日期:2025-09-27卷期号:: PA4096-PA4096
标识
DOI:10.1183/13993003.congress-2025.pa4096
摘要
Dysfunction of vascular endothelial cells is an indispensable factor leading to pulmonary vascular remodeling in pulmonary hypertension (PH). Ubiquitin-specific protease 2a (USP2a) participates in various pathophysiological processes, such as cancer, metabolic diseases and inflammation, by deubiquitinating substrates. However, the role and regulatory mechanism of USP2a in PH are still unclear. This study aims to explore the role and potential mechanisms of USP2a in PH. The expression of USP2a increased in lung tissues of patients with PAH, experimental PH animals, as well as in interleukin-6 (IL-6)-stimulated endothelial cells. Endothelial cell-specific Usp2a knockout and USP2a inhibitor ML364 can alleviate experimental PH. USP2a and methyltransferase like 16 (METTL16) promoted the migratory and angiogenic phenotypes of endothelial cells in vitro. USP2a can attenuate the degradation of METTL16 by deubiquitination. METTL16 did not rely on its methyltransferase function to promote the translation of USP2a mRNA by interacting with eIF3A, thereby forming a positive feedback loop of USP2a-METTL16. Subsequently, METTL16 regulated the m6A modification and stability of IL-6R (IL-6 receptor) mRNA, and further increased the expression of IL-6R. This signaling pathway amplified the IL-6 signaling in endothelial cells, enhanced their migration and angiogenesis abilities, and thus participated in pulmonary vascular remodeling in PH.